(Q34151972)

31 July 2017

The growing diversity and spectrum of action of myeloid-derived suppressor cells (English)

1 reference

31 July 2017

1

1 reference

PubMed ID

21110315

31 July 2017

language of work or name

English

0 references

publication date

1 December 2010

1 reference

European Journal of Immunology

31 July 2017

1 reference

31 July 2017

40

1 reference

31 July 2017

12

1 reference

31 July 2017

3317-3320

1 reference

Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes.

31 July 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Myeloid-derived suppressor cells as regulators of the immune system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Myeloid-derived suppressor cells in inflammation: uncovering cell subsets with enhanced immunosuppressive functions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Altered macrophage differentiation and immune dysfunction in tumor development

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Modulating the expression of IFN regulatory factor 8 alters the protumorigenic behavior of CD11b+Gr-1+ myeloid cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

CD11b+/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1beta-secreting cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Overexpression of interleukin-1beta in the murine pancreas results in chronic pancreatitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Fas signal promotes lung cancer growth by recruiting myeloid-derived suppressor cells via cancer cell-derived PGE2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Cancer-related inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

TIR8/SIGIRR: an IL-1R/TLR family member with regulatory functions in inflammation and T cell polarization

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Immunological and inflammatory functions of the interleukin-1 family

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Neutrophils influence the level of antigen presentation during the immune response to protein antigens in adjuvants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Never Underestimate the Power of a Neutrophil

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Mononuclear myeloid-derived "suppressor" cells express RAE-1 and activate natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Direct and differential suppression of myeloid-derived suppressor cell subsets by sunitinib is compartmentally constrained

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

From phagocyte diversity and activation to probiotics: Back to Metchnikoff

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041170

7 January 2021

Identifiers

DOI

10.1002/EJI.201041170

1 reference

31 July 2017

1 reference

PubMed ID

21110315